Loading...

COVID Pills Show Promise for Combating Severe Infection

January 12, 2022 by Alexa Hornbeck
COVID Pills Show Promise for Combating Severe Infection

Pfizer’s Paxlovid is the first pill treatment to combat severe COVID-19 infection, and new figures from Israel’s Ministry of Health show the pill may hold promise in saving lives.

Shortly before Christmas Day, Paxlovid was authorized for at-home treatment of high-risk COVID-19 infections in patients over the age of 12 by the U.S. Food and Drug Administration.

The FDA granted emergency approval for the treatment, as did Israel’s Ministry of Health, based on Pfizer’s results from a trial of 2,250 patients showing the pill cut hospitalizations and deaths by 89% when given to those with mild to moderate COVID-19 within three days of symptoms. 

The results from the 30-day clinical trial from Pfizer also showed that less than 1% of patients taking the drug were hospitalized and none died when compared to 6.5% of patients who were hospitalized and nine deaths in those who received a placebo.

On Sunday, health officials in Israel administered the first coronavirus pills to two at-risk patients with COVID-19 infections after the first shipment of an estimated 20,000 doses of Pfizer pills arrived in the country the week prior. 

So far, estimates from Pfizer show costs for the pill at about $530.00 per patient treatment, and Pfizer has said that 250,000 treatments should be available in the U.S. by the end of January. 

Merck also has a pill, Molnupiravir, that is pending authorization for use in the U.S. The Pfizer pill has shown fewer side effects and greater efficacy than Merck’s pill, with a nearly 90% reduction in hospitalizations and deaths.

Alexa can be reached at alexa@thewellnews.com

In The News

Health

Voting

Health

Theories Emerge for Mysterious Liver Illnesses in Children

NEW YORK (AP) — Health officials remain perplexed by mysterious cases of severe liver damage in hundreds of young children... Read More

NEW YORK (AP) — Health officials remain perplexed by mysterious cases of severe liver damage in hundreds of young children around the world. The best available evidence points to a fairly common stomach bug that isn't known to cause liver problems in otherwise healthy kids. That... Read More

May 18, 2022
by Alexa Hornbeck
CalAIM Launches Program to Reform Housing and Health Care Coverage in California  

A new program launched this year out of California called CalAIM helps high-risk and low-income Medi-Cal residents find affordable housing... Read More

A new program launched this year out of California called CalAIM helps high-risk and low-income Medi-Cal residents find affordable housing through their health insurance plans. The CalAIM program is intended to improve health outcomes of Medi-Cal enrollees, specifically those with behavioral health needs, seniors, people living... Read More

May 18, 2022
by Alexa Hornbeck
Smart Pacifier Provides Non-Invasive Way to Monitor Babies’ Electrolytes in Hospitals

Researchers from Washington State University released a study on Monday regarding their development of a smart pacifier that can be used to... Read More

Researchers from Washington State University released a study on Monday regarding their development of a smart pacifier that can be used to monitor infant health in hospitals. The wireless, bioelectronic pacifier will eliminate the need for invasive, twice-daily blood draws to monitor babies’ electrolytes in newborn intensive care... Read More

May 18, 2022
by Alexa Hornbeck
WHO and UNICEF Release Report on Role of Assistive Technologies 

The World Health Organization and UNICEF released a report on Monday that finds more than 2.5 billion people need one or more... Read More

The World Health Organization and UNICEF released a report on Monday that finds more than 2.5 billion people need one or more assistive products, such as wheelchairs, hearing aids or apps that support communication and cognition.  Despite the need, nearly 1 billion are denied access to such technologies,... Read More

May 18, 2022
by Alexa Hornbeck
House Committee Advances Legislation for Medication Access and Training for Opioid Addiction 

During a mark-up session on Wednesday, the House Energy and Commerce Committee voted to advance provisions of the Medication Access and Training... Read More

During a mark-up session on Wednesday, the House Energy and Commerce Committee voted to advance provisions of the Medication Access and Training Expansion Act, known as the MATE Act. The legislation is designed to ensure controlled medication prescribers have a baseline knowledge of how to treat patients suffering with... Read More

May 18, 2022
by Alexa Hornbeck
FDA Approves First At-Home Test for Detecting COVID, Flu and RSV

The U.S. Food and Drug Administration authorized the first at-home test that can identify and differentiate multiple respiratory viruses at... Read More

The U.S. Food and Drug Administration authorized the first at-home test that can identify and differentiate multiple respiratory viruses at the same time, detecting influenza A and B, respiratory syncytial virus and SARS-CoV-2, the virus that causes COVID-19.  “While the FDA has now authorized many COVID-19... Read More

News From The Well